NOX1 and pulmonary arterial hypertension: These serotonin effects are amplified in hPASMCs from patients with PAH and involve c-Src–regulated Nox1 and 5-HT1BR and Nrf-2 dysfunction (summarized in Figure X in the online-only Data Supplement).